Results 281 to 290 of about 9,870,305 (401)

PROCEEDINGS OF SEMINAR ON THE USE OF STABLE ISOTOPES IN CLINICAL PHARMACOLOGY, UNIV. OF CHICAGO, NOVEMBER 10--11, 1971.

, 1972
Peter Klein
openalex   +2 more sources

The clinical pharmacology of non‐sedating antihistamines

Pharmacology and Therapeutics, 2017
K. Yanai, T. Yoshikawa, A. Yanai, Tadaho Nakamura, Tomomitsu Iida, R. Leurs, M. Tashiro   +6 more
semanticscholar   +1 more source

Medicines in pregnancy: A clinical pharmacology extrapolation framework to address knowledge gaps. [PDF]

CPT Pharmacometrics Syst Pharmacol
Coppola P, Berglund EG, Rowland Yeo K.
europepmc   +1 more source

From Mechanoelectric Conversion to Tissue Regeneration: Translational Progress in Piezoelectric Materials

Advanced Materials, EarlyView.
This review highlights recent progress in piezoelectric materials for regenerative medicine, emphasizing their ability to convert mechanical stimuli into bioelectric signals that promote tissue repair. Key discussions cover the intrinsic piezoelectric properties of biological tissues, co‐stimulation cellular mechanisms for tissue regeneration, and ...
Xinyu Wang, Sílvio Terra Stefanello, Victor Shahin, Yun Qian   +3 more
wiley   +1 more source

First-in-Human Phase 1 Study to Evaluate the Clinical Pharmacology Properties of RBN-3143, a Novel Inhibitor of Mono-Adenosine Diphosphate Ribosyltransferase-PARP14. [PDF]

Clin Pharmacol Drug Dev
Polasek TM, Cole A, Bozón V, Manyak E, Novak J, Yang B, Johnston BA, Parasuraman S, Paneliya KJ, Schuck V.   +9 more
europepmc   +1 more source

Upconversion Nanoparticle‐Covalent Organic Framework Core–shell Particles as Therapeutic Microrobots Trackable With Optoacoustic Imaging

Advanced Materials, EarlyView.
Upconversion nanoparticle‐covalent organic framework core–shell particles provide enhanced contrast for optoacoustic imaging by leveraging the optical absorption of upconversion luminescence within the covalent organic framework matrix. Beyond their role as contrast agents, these particles enable customizable therapeutic agent loading and release, as ...
Dong Wook Kim, Paul Wrede, Andrés Rodríguez‐Camargo, Yi Chen, Nihal Olcay Dogan, Chaim Glück, Bettina V. Lotsch, Daniel Razansky, Metin Sitti   +8 more
wiley   +1 more source

A Canadian Perspective

PLoS Medicine, 2005
Till James E
doaj   +1 more source

A Pharmacological Study of the Sleep-inducers from the Clinical Viewpoint

, 1972
Masasuke Kimura, Yukihiro Agoh, Yoshiteru Ohno, Hiroshi Ohyama, T Kawano, Kohji Suehiro, T Takayama, Shunji Nakagawa, Kenichi Matsumoto, Shū Mori, Masayuki Moronaga   +10 more
openalex   +2 more sources

To be or not to be, when synthetic data meet clinical pharmacology: A focused study on pharmacogenetics. [PDF]

CPT Pharmacometrics Syst Pharmacol
Woillard JB, Benoist C, Destere A, Labriffe M, Marchello G, Josse J, Marquet P.   +6 more
europepmc   +1 more source

De Novo Design of Integrin α5β1 Modulating Proteins to Enhance Biomaterial Properties

Advanced Materials, EarlyView.
NeoNectins are de novo‐designed miniproteins that selectively bind and stabilize the extended open form of integrin α5β1. When grafted onto biomaterials including hydrogel and titanium, they promote cell attachment and spreading in vitro and promoting tissue integration and bone growth in animal models, demonstrating broad potential for regenerative ...
Xinru Wang, Jordi Guillem‐Marti, Saurav Kumar, David S. Lee, Daniel Cabrerizo‐Aguado, Rachel Werther, Kevin Alexander Estrada Alamo, Yan Ting Zhao, Adam Nguyen, Irina Kopyeva, Buwei Huang, Jing Li, Yuxin Hao, Xinting Li, Aritza Brizuela‐Velasco, Analisa Murray, Stacey Gerben, Anindya Roy, Cole A. DeForest, Timothy Springer, Hannele Ruohola‐Baker, Jonathan A. Cooper, Melody G. Campbell, Jose Maria Manero, Maria‐Pau Ginebra, David Baker   +25 more
wiley   +1 more source